MILLENNIUM MANAGEMENT LLC - 11 Feb 2026 SCHEDULE 13G/A Report for Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SUPN)

Filing Manager
MILLENNIUM MANAGEMENT LLC
Reporting Manager
Millennium Management LLC
Security
Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
SUPN
Shares outstanding
57,572,193 shares
Disclosed Ownership
3,281,615 shares
Ownership
5.7%
Form type
SCHEDULE 13G/A
Filing time
18 Feb 2026, 16:38:59 UTC
Date of event
11 Feb 2026
Previous filing
02 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"MILLENNIUM MANAGEMENT LLC disclosed 5.7% ownership in Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SUPN) on 11 Feb 2026."

Quick Takeaways

  • MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SUPN).
  • Disclosed ownership: 5.7%.
  • Date of event: 11 Feb 2026.

What Changed

  • Previous schedule filing date: 02 Feb 2026.
  • Current filing was accepted on 18 Feb 2026, 16:38.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 4.9% 2,817,883 0 2,817,883 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 5.7% 3,281,615 0 3,281,615 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 5.7% 3,281,615 0 3,281,615 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 5.7% 3,281,615 0 3,281,615 /s/ Israel A. Englander Israel A. Englander

Sponsored